HOME › DRUGS › OXALIPLATIN
ACTIVE SUBSTANCE / INN

OXALIPLATIN

Brand name(s): OXALIPLATIN, ELOXATIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA078816
NDA021492
ACTIVE SUBSTANCE
Oxaliplatin
REGULATORS
FDA
SPONSORS / MAH
QILU PHARM HAINAN, MUSTAFA NEVSAT IIAC SANAYII A.S., SUN PHARM
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OXALIPLATINANDA078818SUN PHARMDiscontinued
OXALIPLATINANDA204616QILU PHARM HAINANPrescription
ELOXATINNDA021492SANOFI AVENTIS USDiscontinued
OXALIPLATINANDA078816MUSTAFA NEVSAT IIAC SANAYII A.S.None (Tentative Approval)

FULL INTELLIGENCE ON OXALIPLATIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →